BRIEF-Idera Pharmaceuticals Inc Says By Decision Dated Jan 10, Nasdaq Panel Granted Co Extension Until Jan 20, To Complete Shareholder Meeting & Attendant Transactions

Reuters2023-01-11

Jan 11 (Reuters) - Idera Pharmaceuticals Inc :

* IDERA - BY DECISION DATED JAN 10, NASDAQ PANEL GRANTED CO EXTENSION UNTIL JAN 20, TO COMPLETE SHAREHOLDER MEETING & ATTENDANT TRANSACTIONS

* IDERA PHARMACEUTICALS INC - CO ANTICIPATES BEING ABLE TO SATISFY TERMS OF NASDAQ HEARING PANEL’S DECISION PRIOR TO JANUARY 20, 2023

Source text for Eikon: Further company coverage:

((reuters.briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2302008888?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-01-11 21:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2302008888","market":"us","top_or_hot":-1,"title":"BRIEF-Idera Pharmaceuticals Inc Says By Decision Dated Jan 10, Nasdaq Panel Granted Co Extension Until Jan 20, To Complete  Shareholder Meeting & Attendant Transactions","media":"Reuters","content":"<html><body><p>Jan 11 (Reuters) - Idera Pharmaceuticals Inc   :</p><p>   * IDERA - BY DECISION DATED JAN 10, NASDAQ PANEL GRANTED CO EXTENSION UNTIL JAN 20, TO COMPLETE  SHAREHOLDER MEETING &amp; ATTENDANT TRANSACTIONS</p><p>   * IDERA PHARMACEUTICALS INC - CO ANTICIPATES BEING ABLE TO SATISFY TERMS OF NASDAQ HEARING PANEL’S DECISION PRIOR TO JANUARY 20, 2023</p><p>Source text for Eikon:    Further company coverage:   </p><p>((reuters.briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Idera Pharmaceuticals Inc Says By Decision Dated Jan 10, Nasdaq Panel Granted Co Extension Until Jan 20, To Complete  Shareholder Meeting & Attendant Transactions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Idera Pharmaceuticals Inc Says By Decision Dated Jan 10, Nasdaq Panel Granted Co Extension Until Jan 20, To Complete  Shareholder Meeting & Attendant Transactions\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-01-11 21:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Jan 11 (Reuters) - Idera Pharmaceuticals Inc   :   * IDERA - BY DECISION DATED JAN 10, NASDAQ PANEL GRANTED CO EXTENSION UNTIL JAN 20, TO COMPLETE  SHAREHOLDER MEETING & ATTENDANT TRANSACTIONS   * ...</p>\n\n<a href=\"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2302008888","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2302008888","pubTimestamp":1673444282,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Jan 11 (Reuters) - Idera Pharmaceuticals Inc   :   * IDERA - BY DECISION DATED JAN 10, NASDAQ PANEL ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","SANA":"Sana Biotechnology, Inc.","ONTF":"ON24, Inc.","BK4196":"保健护理服务","CGEM":"Cullinan Therapeutics","BK4139":"生物科技","APR":"Apria, Inc.","BK4023":"应用软件","LHDX":"Lucira Health, Inc.","BK4007":"制药","LABP":"Landos Biopharma, Inc.","ACGN":"Aceragen, Inc."},"translate_title":"简介-Idera Pharmaceuticals Inc。表示，通过1月10日的决定，纳斯达克小组批准公司延期至1月20日，以完成股东大会和相关交易","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACGN":1,"APR":1,"CGEM":1,"IDRA":1,"LABP":1,"LHDX":1,"ONTF":1,"SANA":1},"content_text":"Jan 11 (Reuters) - Idera Pharmaceuticals Inc   :   * IDERA - BY DECISION DATED JAN 10, NASDAQ PANEL GRANTED CO EXTENSION UNTIL JAN 20, TO COMPLETE  SHAREHOLDER MEETING & ATTENDANT TRANSACTIONS   * IDERA PHARMACEUTICALS INC - CO ANTICIPATES BEING ABLE TO SATISFY TERMS OF NASDAQ HEARING PANEL’S DECISION PRIOR TO JANUARY 20, 2023Source text for Eikon:    Further company coverage:   ((reuters.briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2302008888"}